RGH-188, an atypical antipsychotic with dopamine D3/D2 antagonist/partial agonist properties:: In vitro characterisation

被引：0
|
作者：
Kiss, B. [1 ]
Laszlovszky, I. [1 ]
Horvath, A. [1 ]
Schmidt, E. [1 ]
Bugovics, Gy. [1 ]
Orosz, Sz. [1 ]
Hornok, K. [1 ]
Gyertyan, I. [1 ]
Agai-Csongor, E. [1 ]
Domany, Gy. [1 ]
Tihanyi, K. [1 ]
Szombathelyi, Zs. [1 ]
机构：
[1] G Richter Ltd, Budapest, Hungary
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2006年 / 9卷
关键词：
D-3 RECEPTOR ANTAGONIST;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S221 / S222
页数：2
相关论文
共 50 条
  • [31] CARIPRAZINE, A D3/D2 DOPAMINE RECEPTOR PARTIAL AGONIST ANTIPSYCHOTIC, DISPLAYS GREATER D3 RECEPTOR OCCUPANCY IN VIVO COMPARED WITH OTHER ANTIPSYCHOTICS
    Kiss, Bela
    Horti, Ferenc
    Bobok, Amrita
    SCHIZOPHRENIA RESEARCH, 2012, 136 : S190 - S190
  • [32] F15063, an innovative antipsychotic with D2/D3 antagonist, 5-HT1A agonist and D4 partial agonist properties:: (I) in vitro, neurochemical and neuroendocrine profiles
    Newman-Tancredi, A.
    Assie, M. B.
    Martel, J. C.
    Cosi, C.
    Heusler, P.
    Slot, L. Bruins
    Carilla-Durand, E.
    Cussac, D.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S144 - S145
  • [33] Effects of repeated treatment with the dopamine D2/D3 receptor partial agonist aripiprazole on striatal D2/D3 receptor availability in monkeys
    Paul W. Czoty
    H. Donald Gage
    Pradeep K. Garg
    Sudha Garg
    Michael A. Nader
    Psychopharmacology, 2014, 231 : 613 - 619
  • [34] Effects of repeated treatment with the dopamine D2/D3 receptor partial agonist aripiprazole on striatal D2/D3 receptor availability in monkeys
    Czoty, Paul W.
    Gage, H. Donald
    Garg, Pradeep K.
    Garg, Sudha
    Nader, Michael A.
    PSYCHOPHARMACOLOGY, 2014, 231 (03) : 613 - 619
  • [35] Atypical antipsychotic properties of blonanserin, a novel dopamine D2 and 5-HT2A antagonist
    Ohno, Yukihiro
    Okano, Motoki
    Imaki, Junta
    Tatara, Ayaka
    Okumura, Takahiro
    Shimizu, Saki
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2010, 96 (02) : 175 - 180
  • [36] F15063, a potential antipsychotic with D2/D3 antagonist, 5-HT1A agonist and D4 partial agonist properties:: (I) in vitro receptor affinity and efficacy profile
    Newman-Tancredi, A.
    Assie, M-B
    Martel, J-C
    Cosi, C.
    Slot, L. Bruins
    Palmier, C.
    Rauly-Lestienne, I.
    Colpaert, F.
    Vacher, B.
    Cussac, D.
    BRITISH JOURNAL OF PHARMACOLOGY, 2007, 151 (02) : 237 - 252
  • [37] The dopamine D3 receptor partial agonist, BP 897, is an antagonist at human dopamine D3 receptors and at rat somatodendritic dopamine D3 receptors
    Wicke, K
    Garcia-Ladona, J
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 424 (02) : 85 - 90
  • [38] F15063, a potential antipsychotic with dopamine D2/D3 receptor antagonist, 5-HT1A receptor agonist and dopamine D4 receptor partial agonist properties: Influence on neuronal firing and neurotransmitter release
    Assie, Marie-Bernadette
    Mnie-Filali, Ouissame
    Ravailhe, Veronique
    Benas, Christelle
    Marien, Marc
    Betry, Cecile
    Zimmer, Luc
    Haddjeri, Nasser
    Newman-Tancredi, Adrian
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 607 (1-3) : 74 - 83
  • [39] Pharmacology of aripiprazole, a novel antipsychotic:: dopamine D2 receptor partial agonist
    Kikuchi, T
    Arlene, S
    Yocca, F
    Tadori, Y
    Hirose, T
    McQuade, R
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2004, 19 (03) : 190 - 190
  • [40] Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist
    Chien, Ellen Y. T.
    Liu, Wei
    Zhao, Qiang
    Katritch, Vsevolod
    Han, Gye Won
    Hanson, Michael A.
    Shi, Lei
    Newman, Amy Hauck
    Javitch, Jonathan A.
    Cherezov, Vadim
    Stevens, Raymond C.
    SCIENCE, 2010, 330 (6007) : 1091 - 1095
12345